Bullous pemphigoid
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
localised lesions in children or adults
topical corticosteroids or topical tacrolimus
Localised disease may be successfully managed with high-potency topical corticosteroids, with or without occlusion.[35]Cotell S, Robinson ND, Chan LS. Autoimmune blistering skin diseases. Am J Emerg Med. 2000;18:288-299. http://www.ncbi.nlm.nih.gov/pubmed/10830686?tool=bestpractice.com [41]Bernard P, Charneux J. Bullous pemphigoid: a review [in French]. Ann Dermatol Venereol. 2011;138:173-181. http://www.ncbi.nlm.nih.gov/pubmed/21397147?tool=bestpractice.com
Widespread application of potent topical corticosteroids (such as fluorinated corticosteroids) over a large body surface area may result in significant systemic absorption and should be avoided. Use of occlusion enhances the effect of the topical corticosteroid, but also increases absorption, so it should be limited to small body surface areas and only several days at a time.
Individual case reports described a response to topical treatment with tacrolimus, a calcineurin inhibitor. Topical tacrolimus causes more local irritation than topical corticosteroids, but it may be useful as an alternative in localised and limited disease without the disadvantage of causing skin atrophy.[38]Venning VA, Taghipour K, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. Br J Dermatol. 2012;167:1200-14. http://onlinelibrary.wiley.com/doi/10.1111/bjd.12072/full http://www.ncbi.nlm.nih.gov/pubmed/23121204?tool=bestpractice.com
Primary options
clobetasol topical: (0.05%) apply sparingly to the affected area(s) twice daily for up to 2 weeks
Secondary options
tacrolimus topical: (0.1%) apply sparingly to the affected area(s) twice daily for up to 2 weeks
sedating antihistamines
Additional treatment recommended for SOME patients in selected patient group
Itch is usually controlled with the use of oral sedating antihistamines, such as hydroxyzine or diphenhydramine.
Primary options
hydroxyzine: children ≤40 kg: 2 mg/kg/day orally given in divided doses every 6-8 hours when required ; children >40 kg and adults: 25 mg orally every 6-8 hours when required, maximum 100 mg/day
OR
diphenhydramine: children 2-6 years of age: 6.25 mg orally/intravenously/intramuscularly every 4-6 hours when required; children 6-12 years of age: 12.5 to 25 mg orally/intravenously/intramuscularly every 4-6 hours when required; adults: 25-50 mg orally/intravenously/intramuscularly every 4-6 hours when required
widespread lesions in adults
oral corticosteroids
Most patients will respond well to systemic corticosteroids. However, it is essential to use systemic corticosteroids for the shortest duration and at the lowest dose possible, to avoid serious adverse effects. Starting doses of prednisolone >0.75 mg/kg/day may not give additional benefit. Lower doses may be adequate to control disease and reduce the incidence and severity of adverse reactions.[37]Kirtschig G, Middleton P, Bennett C, et al. Interventions for bullous pemphigoid. Cochrane Database Syst Rev. 2010;(10):CD002292.
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002292.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/20927731?tool=bestpractice.com
[ ]
How do prednisolone/prednisone, alone or in combination with other interventions affect outcomes in people with bullous pemphigoid?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.506/fullShow me the answer
The initial dose is maintained until cessation of new blister formation. It is then slowly tapered over 6 to 9 months.
Primary options
prednisolone: 0.5 to 2 mg/kg/day orally
sedating antihistamines
Additional treatment recommended for SOME patients in selected patient group
Itch is usually controlled with the use of oral sedating antihistamines, such as hydroxyzine or diphenhydramine.
Primary options
hydroxyzine: 25 mg orally every 6-8 hours when required, maximum 100 mg/day
OR
diphenhydramine: 25-50 mg orally/intravenously/intramuscularly every 4-6 hours when required
oral corticosteroids plus antibiotic therapy
Most patients will respond well to systemic corticosteroids. However, it is essential to use systemic corticosteroids for the shortest duration and at the lowest dose possible, to avoid serious adverse effects. The initial dose is maintained until cessation of new blister formation. It is then slowly tapered over 6 to 9 months.
The addition of antibiotics is considered for corticosteroid-sparing if long-term use is anticipated.[9]Ujiie H, Iwata H, Yamagami J, et al. Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita). J Dermatol. 2019 Dec;46(12):1102-35. https://www.doi.org/10.1111/1346-8138.15111 http://www.ncbi.nlm.nih.gov/pubmed/31646663?tool=bestpractice.com [38]Venning VA, Taghipour K, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. Br J Dermatol. 2012;167:1200-14. http://onlinelibrary.wiley.com/doi/10.1111/bjd.12072/full http://www.ncbi.nlm.nih.gov/pubmed/23121204?tool=bestpractice.com
If antibiotics such as tetracycline plus nicotinamide are added, corticosteroids may be tapered and stopped more rapidly (over several months).
Nicotinamide is used in combination with antibiotics and appears to have anti-inflammatory properties. It may act as a histamine receptor antagonist and has also has been reported to inhibit eosinophil and neutrophil chemotaxis and secretion.[39]Bekier E, Maslinski C. Antihistaminic action of nicotinamide. Agents Actions. 1974;4:196. http://www.ncbi.nlm.nih.gov/pubmed/4153281?tool=bestpractice.com Nicotinamide lacks the vasodilator, gastrointestinal, hepatic, and hypolipaemic actions of nicotinic acid. As such, nicotinamide has not been shown to produce the flushing, itching, and burning sensations of the skin as is commonly seen when large doses of nicotinic acid are given orally.[40]Kirtschig G, Khumalo NP. Management of bullous pemphigoid: recommendations for immunomodulatory treatments. Am J Clin Dermatol. 2004;5:319-26. http://www.ncbi.nlm.nih.gov/pubmed/15554733?tool=bestpractice.com
On successful treatment of blisters, the antibiotics and nicotinamide should be slowly tapered over several months to avoid a relapse.[38]Venning VA, Taghipour K, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. Br J Dermatol. 2012;167:1200-14. http://onlinelibrary.wiley.com/doi/10.1111/bjd.12072/full http://www.ncbi.nlm.nih.gov/pubmed/23121204?tool=bestpractice.com
Primary options
prednisolone: 0.5 to 2 mg/kg/day orally
-- AND --
nicotinamide: 500-2000 mg orally once daily at bedtime
-- AND --
tetracycline: 250-500 mg orally four times daily
or
doxycycline: 50-100 mg orally once or twice daily
or
minocycline: 50-100 mg orally once or twice daily
or
erythromycin base: 333 mg orally (delayed-release) three times daily
ciclosporin
Additional treatment recommended for SOME patients in selected patient group
Ciclosporin can be added to the combination therapy as a corticosteroid-sparing drug; the systemic corticosteroids would then be slowly tapered over weeks to months while the patient continues taking antibiotics. A slow corticosteroid taper depends on the patient's starting dose and duration of therapy, and is adjusted to the clinical response of the patient once the disease process is stable.
The evidence for benefit with ciclosporin is conflicting, even with relatively high doses of >6 mg/kg/day, and responses mainly occurred in patients treated with concomitant oral corticosteroids.[37]Kirtschig G, Middleton P, Bennett C, et al. Interventions for bullous pemphigoid. Cochrane Database Syst Rev. 2010;(10):CD002292. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002292.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/20927731?tool=bestpractice.com
Primary options
ciclosporin: 2.5 to 4 mg/kg/day orally given in 2 divided doses
More ciclosporinBioavailability may differ between brands
sedating antihistamines
Additional treatment recommended for SOME patients in selected patient group
Itch is usually controlled with the use of oral sedating antihistamines, such as hydroxyzine or diphenhydramine.
Primary options
hydroxyzine: 25 mg orally every 6-8 hours when required, maximum 100 mg/day
OR
diphenhydramine: 25-50 mg orally/intravenously/intramuscularly every 4-6 hours when required
dapsone or antibiotic therapy or immunosuppressants
If corticosteroid treatment is contraindicated for those with systemic lesions, alternative treatments exist.[30]Santi CG, Gripp AC, Roselino AM, et al. Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology. An Bras Dermatol. 2019 Apr;94(2 suppl 1):33-47. https://www.doi.org/10.1590/abd1806-4841.2019940207 http://www.ncbi.nlm.nih.gov/pubmed/31166405?tool=bestpractice.com
Dapsone is used, especially if patients have a neutrophil-rich infiltrate. It is contraindicated in glucose-6-phosphate dehydrogenase (G6PD) deficiency. G6PD deficiency predisposes to haematological adverse effects of dapsone and should be excluded in predisposed races.[38]Venning VA, Taghipour K, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. Br J Dermatol. 2012;167:1200-14. http://onlinelibrary.wiley.com/doi/10.1111/bjd.12072/full http://www.ncbi.nlm.nih.gov/pubmed/23121204?tool=bestpractice.com In the US, black males are most commonly affected, with a prevalence of approximately 10%.
Other options are a combination of tetracycline and nicotinamide, and immunosuppressive drugs.
Nicotinamide is used in combination with antibiotics and appears to have anti-inflammatory properties. It may act as a histamine receptor antagonist and has also has been reported to inhibit eosinophil and neutrophil chemotaxis and secretion.[39]Bekier E, Maslinski C. Antihistaminic action of nicotinamide. Agents Actions. 1974;4:196. http://www.ncbi.nlm.nih.gov/pubmed/4153281?tool=bestpractice.com Nicotinamide lacks the vasodilator, gastrointestinal, hepatic, and hypolipaemic actions of nicotinic acid. As such, nicotinamide has not been shown to produce the flushing, itching, and burning sensations of the skin as is commonly seen when large doses of nicotinic acid are given orally.[40]Kirtschig G, Khumalo NP. Management of bullous pemphigoid: recommendations for immunomodulatory treatments. Am J Clin Dermatol. 2004;5:319-26. http://www.ncbi.nlm.nih.gov/pubmed/15554733?tool=bestpractice.com
On successful treatment of blisters, the antibiotics and nicotinamide should be slowly tapered over several months to avoid a relapse.[38]Venning VA, Taghipour K, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. Br J Dermatol. 2012;167:1200-14. http://onlinelibrary.wiley.com/doi/10.1111/bjd.12072/full http://www.ncbi.nlm.nih.gov/pubmed/23121204?tool=bestpractice.com
Methotrexate is considered in patients with concomitant psoriasis and bullous pemphigoid in the hands of practitioners with experience using antimetabolites. Methotrexate should include folic acid or calcium folinate as part of the regimen.
Primary options
dapsone: 50 mg orally once daily
OR
nicotinamide: 500-2000 mg orally once daily at bedtime
-- AND --
tetracycline: 250-500 mg orally four times daily
or
doxycycline: 50-100 mg orally once or twice daily
or
minocycline: 50-100 mg orally once or twice daily
or
erythromycin base: 333 mg orally (delayed-release) three times daily
OR
methotrexate: 7.5 mg orally/intramuscularly once weekly on the same day of each week initially, increase gradually according to response, maximum 25 mg/week; or 2.5 to 7.5 mg orally every 12 hours for 3 doses per week; use lowest effective dose
-- AND --
folic acid: 1 mg orally once daily (except on day when methotrexate is given)
or
calcium folinate: 5 mg orally once weekly (on a different day to when methotrexate is given)
OR
azathioprine: 50-200 mg orally once daily, adjust according to response, maximum 2.5 mg/kg/day
OR
mycophenolate mofetil: 500-1000 mg orally twice daily
OR
chlorambucil: 6 mg orally once daily
OR
cyclophosphamide: 2-3 mg/kg/day orally
sedating antihistamines
Additional treatment recommended for SOME patients in selected patient group
Itch is usually controlled with the use of oral sedating antihistamines, such as hydroxyzine or diphenhydramine.
Primary options
hydroxyzine: 25 mg orally every 6-8 hours when required, maximum 100 mg/day
OR
diphenhydramine: 25-50 mg orally/intravenously/intramuscularly every 4-6 hours when required
prednisolone plus immunosuppressant or immunosuppressant alone
If the patient requires high doses of systemic corticosteroids for maintenance or is not showing a clinical response, other immunosuppressive (corticosteroid-sparing) agents, such as azathioprine, mycophenolate, or ciclosporin, may be added.
Other therapies for severe generalised disease include cyclophosphamide and methotrexate.[35]Cotell S, Robinson ND, Chan LS. Autoimmune blistering skin diseases. Am J Emerg Med. 2000;18:288-299. http://www.ncbi.nlm.nih.gov/pubmed/10830686?tool=bestpractice.com
The initial dose of prednisolone is maintained until new blister formation ceases. It is then slowly tapered over 6 to 9 months.
Methotrexate is considered in patients with concomitant psoriasis and bullous pemphigoid in the hands of practitioners with experience using antimetabolites. Methotrexate should include folic acid or calcium folinate as part of the regimen.
There is currently insufficient evidence to recommend routine addition of azathioprine to systemic corticosteroids. Because of its side effects, azathioprine should be considered as an adjunctive treatment to prednisolone only when response has been inadequate and the disease is not suppressed, or where the side effects of existing therapy are unacceptable.[38]Venning VA, Taghipour K, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. Br J Dermatol. 2012;167:1200-14. http://onlinelibrary.wiley.com/doi/10.1111/bjd.12072/full http://www.ncbi.nlm.nih.gov/pubmed/23121204?tool=bestpractice.com
The evidence for benefit with ciclosporin is conflicting, even with relatively high doses of >6 mg/kg/day, and responses mainly occurred in patients treated with concomitant oral corticosteroids.[37]Kirtschig G, Middleton P, Bennett C, et al. Interventions for bullous pemphigoid. Cochrane Database Syst Rev. 2010;(10):CD002292. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002292.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/20927731?tool=bestpractice.com
Primary options
prednisolone: 0.5 to 1 mg/kg/day orally
-- AND --
azathioprine: 50-200 mg orally once daily, adjust according to response, maximum 2.5 mg/kg/day
or
mycophenolate mofetil: 500-1000 mg orally twice daily
or
ciclosporin: 2.5 to 4 mg/kg/day orally given in 2 divided doses
More ciclosporinBioavailability may differ between brands
OR
cyclophosphamide: 2-3 mg/kg/day orally
OR
methotrexate: 7.5 mg orally/intramuscularly once weekly on the same day of each week initially, increase gradually according to response, maximum 25 mg/week; or 2.5 to 7.5 mg orally every 12 hours for 3 doses per week; use lowest effective dose
-- AND --
folic acid: 1 mg orally once daily (except on day when methotrexate is given)
or
calcium folinate: 5 mg orally once weekly (on a different day to when methotrexate is given)
sedating antihistamines
Additional treatment recommended for SOME patients in selected patient group
Itch is usually controlled with the use of oral sedating antihistamines, such as hydroxyzine or diphenhydramine.
Primary options
hydroxyzine: 25 mg orally every 6-8 hours when required, maximum 100 mg/day
OR
diphenhydramine: 25-50 mg orally/intravenously/intramuscularly every 4-6 hours when required
plasmapheresis or intravenous immunoglobulin (IVIG) and/or rituximab
Plasmapheresis or IVIG and/or rituximab are used if all other treatment options fail.
The total published experience of IVIG in bullous pemphigoid is very small and suggests that it is of limited value. It produced some dramatic but short-lived responses.[43]Wetter DA, Davis MD, Yiannias JA, et al. Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experience. Mayo Clin Proc. 2005;80:41-47. http://www.ncbi.nlm.nih.gov/pubmed/15667028?tool=bestpractice.com
Rituximab alone or the combination of rituximab and intravenous immunoglobulin or immuno-adsorption appears to be advantageous in severe cases.[45]Schulze J, Bader P, Henke U, et al. Severe bullous pemphigoid in an infant - successful treatment with rituximab. Pediatr Dermatol. 2008;25:462-465. http://www.ncbi.nlm.nih.gov/pubmed/18789089?tool=bestpractice.com [46]Schmidt E, Bröcker EB, Goebeler M. Rituximab in treatment-resistant autoimmune blistering skin disorders. Clin Rev Allergy Immunol. 2008;34:56-64. http://www.ncbi.nlm.nih.gov/pubmed/18270859?tool=bestpractice.com [47]Reguiaï Z, Tchen T, Perceau G, et al. Efficacy of rituximab in a case of refractory bullous pemphigoid [in French]. Ann Dermatol Venereol. 2009;136:431-434. http://www.ncbi.nlm.nih.gov/pubmed/19442800?tool=bestpractice.com [48]Peterson JD, Chan LS. Effectiveness and side effects of anti-CD20 therapy for autoantibody-mediated blistering skin diseases: a comprehensive survey of 71 consecutive patients from the initial use to 2007. Ther Clin Risk Manag. 2009;5:1-7. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697541/?tool=pubmed http://www.ncbi.nlm.nih.gov/pubmed/19436603?tool=bestpractice.com
Primary options
plasmapheresis
OR
normal immunoglobulin human: 400 mg/kg/day intravenously for 5 days
and/or
rituximab: consult specialist for guidance on dose
sedating antihistamines
Additional treatment recommended for SOME patients in selected patient group
Itch is usually controlled with the use of oral sedating antihistamines, such as hydroxyzine or diphenhydramine.
Primary options
hydroxyzine: 25 mg orally every 6-8 hours when required, maximum 100 mg/day
OR
diphenhydramine: 25-50 mg orally/intravenously/intramuscularly every 4-6 hours when required
widespread lesions in children
oral corticosteroids
Most patients will respond well to systemic corticosteroids. However, it is essential to use systemic corticosteroids for the shortest duration and at the lowest dose possible, to avoid serious adverse effects.
The initial dose is maintained until new blister formation ceases. It is then slowly tapered over 6 to 9 months.
Primary options
prednisolone: 0.5 to 2 mg/kg/day orally
sedating antihistamines
Additional treatment recommended for SOME patients in selected patient group
Itch is usually controlled with the use of oral sedating antihistamines, such as hydroxyzine or diphenhydramine.
Primary options
hydroxyzine: children ≤40 kg: 2 mg/kg/day orally given in divided doses every 6-8 hours when required ; children >40 kg: 25 mg orally every 6-8 hours when required, maximum 100 mg/day
OR
diphenhydramine: children 2-6 years of age: 6.25 mg orally/intravenously/intramuscularly every 4-6 hours when required; children 6-12 years of age: 12.5 to 25 mg orally/intravenously/intramuscularly every 4-6 hours when required
oral corticosteroids plus antibiotic therapy
Most patients will respond well to systemic corticosteroids. However, it is essential to use systemic corticosteroids for the shortest duration and at the lowest dose possible, to avoid serious adverse effects. The initial dose is maintained until new blister formation ceases. It is then slowly tapered over 6 to 9 months.
The addition of antibiotics is considered for corticosteroid-sparing if long-term use is anticipated.[9]Ujiie H, Iwata H, Yamagami J, et al. Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita). J Dermatol. 2019 Dec;46(12):1102-35. https://www.doi.org/10.1111/1346-8138.15111 http://www.ncbi.nlm.nih.gov/pubmed/31646663?tool=bestpractice.com [38]Venning VA, Taghipour K, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. Br J Dermatol. 2012;167:1200-14. http://onlinelibrary.wiley.com/doi/10.1111/bjd.12072/full http://www.ncbi.nlm.nih.gov/pubmed/23121204?tool=bestpractice.com If antibiotics such as tetracycline plus nicotinamide are added, corticosteroids may be tapered and stopped more rapidly (over several months).
Nicotinamide is used in combination with antibiotics and appears to have anti-inflammatory properties. It may act as a histamine receptor antagonist and has also has been reported to inhibit eosinophil and neutrophil chemotaxis and secretion.[39]Bekier E, Maslinski C. Antihistaminic action of nicotinamide. Agents Actions. 1974;4:196. http://www.ncbi.nlm.nih.gov/pubmed/4153281?tool=bestpractice.com Nicotinamide lacks the vasodilator, gastrointestinal, hepatic, and hypolipaemic actions of nicotinic acid. As such, nicotinamide has not been shown to produce the flushing, itching, and burning sensations of the skin as is commonly seen when large doses of nicotinic acid are given orally.[40]Kirtschig G, Khumalo NP. Management of bullous pemphigoid: recommendations for immunomodulatory treatments. Am J Clin Dermatol. 2004;5:319-26. http://www.ncbi.nlm.nih.gov/pubmed/15554733?tool=bestpractice.com
On successful treatment of blisters, the antibiotics and nicotinamide should be slowly tapered over several months to avoid a relapse.[38]Venning VA, Taghipour K, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. Br J Dermatol. 2012;167:1200-14. http://onlinelibrary.wiley.com/doi/10.1111/bjd.12072/full http://www.ncbi.nlm.nih.gov/pubmed/23121204?tool=bestpractice.com
Primary options
prednisolone: 0.5 to 2 mg/kg/day orally
and
erythromycin base: 30-50 mg/kg/day orally given in divided doses every 6-8 hours
and
nicotinamide: 500-2000 mg orally once daily at bedtime
ciclosporin
Additional treatment recommended for SOME patients in selected patient group
In children, there are reports of success with ciclosporin in the more resistant cases. Ciclosporin can be added to the combination therapy as a corticosteroid-sparing drug; the systemic corticosteroids would then be slowly tapered over weeks to months while the patient continues taking antibiotics. A slow corticosteroid taper depends on the patient's starting dose and duration of therapy, and is adjusted to the clinical response of the patient once the disease process is stable.
The evidence for benefit with ciclosporin is conflicting, even with relatively high doses of >6 mg/kg/day, and responses mainly occurred in patients treated with concomitant oral corticosteroids.[37]Kirtschig G, Middleton P, Bennett C, et al. Interventions for bullous pemphigoid. Cochrane Database Syst Rev. 2010;(10):CD002292. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002292.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/20927731?tool=bestpractice.com
Primary options
ciclosporin: 2.5 to 4 mg/kg/day orally given in 2 divided doses
More ciclosporinBioavailability may differ between brands
sedating antihistamines
Additional treatment recommended for SOME patients in selected patient group
Itch is usually controlled with the use of oral sedating antihistamines, such as hydroxyzine or diphenhydramine.
Primary options
hydroxyzine: children ≤40 kg: 2 mg/kg/day orally given in divided doses every 6-8 hours when required ; children >40 kg: 25 mg orally every 6-8 hours when required, maximum 100 mg/day
OR
diphenhydramine: children 2-6 years of age: 6.25 mg orally/intravenously/intramuscularly every 4-6 hours when required; children 6-12 years of age: 12.5 to 25 mg orally/intravenously/intramuscularly every 4-6 hours when required
antibiotic therapy or dapsone
Children who have contraindications for corticosteroid therapy are often treated initially with erythromycin and niacin or dapsone.
Dapsone is used, especially if patients have a neutrophil-rich infiltrate. It is contraindicated in glucose-6-phosphate dehydrogenase (G6PD) deficiency. G6PD deficiency predisposes to haematological adverse effects of dapsone and should be excluded in predisposed races.[38]Venning VA, Taghipour K, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. Br J Dermatol. 2012;167:1200-14. http://onlinelibrary.wiley.com/doi/10.1111/bjd.12072/full http://www.ncbi.nlm.nih.gov/pubmed/23121204?tool=bestpractice.com In the US, black males are most commonly affected, with a prevalence of approximately 10%.
Other options are a combination of tetracycline and nicotinamide, and immunosuppressive drugs.
Nicotinamide is used in combination with antibiotics and appears to have anti-inflammatory properties. It may act as a histamine receptor antagonist and has also has been reported to inhibit eosinophil and neutrophil chemotaxis and secretion.[39]Bekier E, Maslinski C. Antihistaminic action of nicotinamide. Agents Actions. 1974;4:196. http://www.ncbi.nlm.nih.gov/pubmed/4153281?tool=bestpractice.com Nicotinamide lacks the vasodilator, gastrointestinal, hepatic, and hypolipaemic actions of nicotinic acid. As such, nicotinamide has not been shown to produce the flushing, itching, and burning sensations of the skin as is commonly seen when large doses of nicotinic acid are given orally.[40]Kirtschig G, Khumalo NP. Management of bullous pemphigoid: recommendations for immunomodulatory treatments. Am J Clin Dermatol. 2004;5:319-26. http://www.ncbi.nlm.nih.gov/pubmed/15554733?tool=bestpractice.com
On successful treatment of blisters, the antibiotics and nicotinamide should be slowly tapered over several months to avoid a relapse.[38]Venning VA, Taghipour K, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. Br J Dermatol. 2012;167:1200-14. http://onlinelibrary.wiley.com/doi/10.1111/bjd.12072/full http://www.ncbi.nlm.nih.gov/pubmed/23121204?tool=bestpractice.com
Primary options
nicotinamide: 500-2000 mg orally once daily at bedtime
and
erythromycin base: 30-50 mg/kg/day orally given in divided doses every 6-8 hours
OR
dapsone: 2 mg/kg/day orally
sedating antihistamines
Additional treatment recommended for SOME patients in selected patient group
Itch is usually controlled with the use of oral sedating antihistamines, such as hydroxyzine or diphenhydramine.
Primary options
hydroxyzine: children ≤40 kg: 2 mg/kg/day orally given in divided doses every 6-8 hours when required ; children >40 kg: 25 mg orally every 6-8 hours when required, maximum 100 mg/day
OR
diphenhydramine: children 2-6 years of age: 6.25 mg orally/intravenously/intramuscularly every 4-6 hours when required; children 6-12 years of age: 12.5 to 25 mg orally/intravenously/intramuscularly every 4-6 hours when required
dapsone or chlorambucil or high-dose intravenous methylprednisolone
In children, there are reports of success with dapsone and chlorambucil in the more resistant cases. Note that dapsone is contraindicated in glucose-6-phosphate dehydrogenase (G6PD) deficiency. High-dose intravenous methylprednisolone therapy has also been shown effective. In most, remission is achieved within the first year.
Primary options
dapsone: 2 mg/kg/day orally
OR
chlorambucil: consult specialist for guidance on dose
OR
methylprednisolone: 4-48 mg/day intravenously given in 4 divided doses
sedating antihistamines
Additional treatment recommended for SOME patients in selected patient group
Itch is usually controlled with the use of oral sedating antihistamines, such as hydroxyzine or diphenhydramine.
Primary options
hydroxyzine: children ≤40 kg: 2 mg/kg/day orally given in divided doses every 6-8 hours when required ; children >40 kg: 25 mg orally every 6-8 hours when required, maximum 100 mg/day
OR
diphenhydramine: children 2-6 years of age: 6.25 mg orally/intravenously/intramuscularly every 4-6 hours when required; children 6-12 years of age: 12.5 to 25 mg orally/intravenously/intramuscularly every 4-6 hours when required
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer